Article Text

Download PDFPDF
What is the actual cost of providing the intrauterine system for contraception in a UK community sexual and reproductive health setting?
  1. Louise Cook1,
  2. Charlotte Fleming2
  1. 1Associate Specialist, Aneurin Bevan Health Board – Sexual and Reproductive Healthcare, Llanfrechfa Grange Hospital, Gwent, UK
  2. 2Consultant, Sexual and Reproductive Health, Aneurin Bevan Health Board – Sexual and Reproductive Healthcare, Llanfrechfa Grange Hospital, Gwent, UK
  1. Correspondence to Dr Louise Cook, Aneurin Bevan Health Board – Sexual and Reproductive Healthcare, Llanyrafon House, Llanfrechfa Grange, Torfaen, Cwmbran NP44 8YN, UK; Louise_cook{at}yahoo.com

Abstract

Background The anticipated increase in uptake of intrauterine system (IUS) fittings is slower than predicted by the National Institute for Health and Clinical Excellence (NICE). There is evidence to suggest that this is because of a high perceived cost of providing this contraceptive method. Whereas studies to date have all guessed at these costs, we calculated the actual costs of providing the IUS.

Methods We tracked the notes of 283 women who had an IUS fitted in our community sexual and reproductive health service for 5 years. We recorded duration of use, measured the actual cost of all appointments and interventions over the lifespan of the device, and compared our findings with NICE predicted costs.

Results With 70% complete follow-up, the average duration of use of the IUS was 3.44 years compared to NICE's prediction of 3.32. The average annual cost of providing an IUS for contraception in community clinics was £54.55 per woman; this compares with £70.49 modelled by NICE for provision in primary care. Most (80%) of the cost is incurred in the first year. The cost of managing problems is small.

Conclusions Providing the IUS for contraception was 23% cheaper in the present study than that predicted by NICE and cheaper than providing combined oral contraception in our service. Fitting IUSs in community clinics may be cheaper than in primary care. Streamlining the patient pathway will reduce costs further. Restricting access to the IUS because of initial cost is a false economy.

  • family planning service provision
  • intrauterine systems
  • long-acting reversible contraception
  • service delivery
  • health economics

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • Highlights from this issue
    British Medical Journal Publishing Group